HRTX
HRTX clinical trials: HERON THERAPEUTICS, INC. /DE/
Every trial on ClinicalTrials.gov where HERON THERAPEUTICS, INC. /DE/ is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 29
- Trials linked
- 26
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
HRTX on the catalyst calendar · HRTX registry changes
- Primary completion Sep 18, 2023ActualPhase 4NCT05434663Safety Study of Repeat Doses of SUSTOL in AdultsHeron Therapeutics · Chemotherapy-Induced Nausea and Vomiting (CINV)CompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 3, 2021ActualPhase 2NCT03955211PK and Safety After C-SectionHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 29, 2022ActualPhase 4NCT06109428Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Heron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 18, 2022ActualPhase 4NCT06109415Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Heron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 8, 2018ActualPhase 4NCT03705065Bupivacaine HCl PK and Safety in Augmentation MammoplastyHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2015ActualPhase 2NCT02471898HTX-011 for Post-bunionectomy AnalgesiaHeron Therapeutics · AnalgesiaCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2021ActualPhase 1/Phase 2NCT04398329Dose-Escalation Study of HTX-034 Following BunionectomyHeron Therapeutics · BunionsCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2025Sponsor estimatePhase 2NCT03922048Pediatric Postoperative Analgesia Herniorrhaphy StudyHeron Therapeutics · AnalgesiaWithdrawnHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 25, 2021ActualPhase 3NCT03907176Study of Post-Herniorrhaphy Non-opioid MMA RegimensHeron Therapeutics · AnalgesiaCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2017ActualPhase 2NCT02762929Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following BunionectomyHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 9, 2021ActualPhase 2NCT04470622Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)Heron Therapeutics · COVID-19TerminatedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 7, 2020ActualPhase 3NCT03974932Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenHeron Therapeutics · AnalgesiaCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2019ActualPhase 2NCT03718039Phase 2 Bunionectomy HTX-011 Administration StudyHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 20, 2018ActualPhase 2NCT03695367Phase 2 Herniorrhaphy Study for Opioid EliminationHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 8, 2018ActualPhase 3NCT03295721Bunionectomy Study for Postoperative Analgesia (EPOCH 1)Heron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 22, 2017ActualPhase 3NCT03237481Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)Heron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2018ActualPhase 2NCT03015532Total Knee Arthroplasty Infiltration Study for Postoperative AnalgesiaHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 1, 2018ActualPhase 2NCT03011333Phase 2B Upper Extremity Nerve Block StudyHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2017ActualPhase 2NCT02689258Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty SurgeryHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2017ActualPhase 2NCT02504580Pilot Herniorrhaphy Study for Postoperative AnalgesiaHeron Therapeutics · Postoperative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2015ActualPhase 3NCT02106494A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HECHeron Therapeutics · Chemotherapy-induced Nausea and VomitingCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2011ActualNo phase registeredNCT01416259A Phase I Study of the Effects of APF530 Exposure, Granisetron and MoxifloxacinHeron Therapeutics · HealthyCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2008ActualPhase 3NCT00343460APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving...Heron Therapeutics · Nausea and VomitingCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2024Sponsor estimatePhase 4NCT05109312A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.Heron Therapeutics · AnalgesiaActive, not recruitingHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 29, 2022ActualPhase 2NCT04911062HTX-011 in Spinal SurgeryHeron Therapeutics · Post-Operative PainCompletedHRTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 4 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner